Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/9bkcr3/injectable_drug) has announced the addition of the "Injectable Drug Delivery Devices, Markets, Forecasts" report to their offering.
This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes.
What You Will Learn
- What injectable drugs are currently marketed, how are they administered, what are the device specifics, and who markets them?
- What are the injection device types that are driving the market? What is their market share and who are the leading suppliers?
- What new injection device classes have recently been launched and was is their probable impact going to be on the injectables sector?
- What does the injectable drugs supply chain consist of, who are the key suppliers, their manufacturing infrastructure and locations, their capabilities?
- What are the major factors driving injectable drug demand?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What is the size & breakdown of the injectable drug market today? What will it look like in 2022?
Key Topics Covered:
1. Executive Summary
2. Injectable Drug Market Dynamics
- The Injectable Drug Ecosystem
- Injectable Drug Demand Drivers
- Drug Development Factors
- Market Factors
- Technology Factors
- Competitive Landscape
- Risks and Opportunities
3. Injectable Drug-Device Selection Criteria
- Stability and Material Selection Issues
- Single vs Multi-Dose Devices
- Lyophilized Drugs/Reconstitution
- Syringe Safety/Sharps Protection
- Needle Configuration Strategies
- Disposable Drug Cartridges
- Human Engineering/Ergonomics
- Branding/Private Labeling
4. Injectable Drug Delivery - Device Segments
- Autoinjectors
- Autoinjector-specific Selection Factors
- Autoinjector Device Categories
- Drugs and Therapeutic Segments
- Needle-free Injectors
- Device Categories
- Needle-free Injector-specific Selection Factor Pen Injectors
- Pen Injector Device Categories
- Branded Drug/Pen Injector Product by Segment
- Prefilled Syringe Device Categories
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
- Safety Syringes
- Prefillable Integrated Safety Syringes
- Non-Prefillable Integrated Safety Syringes
- Wearable Injectors
- Patch Injectors
- Subcutaneous Infusion Devices
5. Injectable Drug Delivery - Therapeutic Segment
- Analysis & Forecasts
- Anaphylaxis
- Anticoagulants
- Antivirals
- Autoimmune Diseases
- Emergency Medicine
- Hematopoietics
- Hormone Replacement
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines
6. Injectable Drug Therapeutics - Market Factors
- Regulatory Factors and Issues
- Sharps Legislations
- Managed Care & Healthcare Economics
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/9bkcr3/injectable_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 



